Invesco
JBIO

Invesco’s Jade Biosciences JBIO Stock Holding History

Invesco’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$415K Sell
29,560
-170,167
-85% -$2.46M ﹤0.01% 3227
2025
Q4 		$3.08M Buy
199,727
+165,151
+478% +$1.94M ﹤0.01% 2440
2025
Q3 		$298K Buy
+34,576
New +$283K ﹤0.01% 3420
2025
Q2 		– Sell
-2,127
Closed -$187K – 3772
2025
Q1 		$187K Buy
+2,127
New +$187K ﹤0.01% 3526
2023
Q1 		– Sell
-2,074
Closed -$2.13M – 3872
2022
Q4 		$2.13M Buy
+2,074
New +$1.51M ﹤0.01% 2625

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Invesco's JBIO Position: Q1 2026 in Review

Invesco reduced its Jade Biosciences (JBIO) stake by 85% in Q1 2026, selling an estimated $2.46M and leaving 29,560 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #3227.

Invesco first reported a position in JBIO in Q4 2022 and has held it in 5 quarters since. The position peaked at $3.08M in Q4 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Invesco held 29,560 shares of Jade Biosciences worth $415K as of Q1 2026.
  • Invesco sold 170,167 Jade Biosciences shares in Q1 2026, an estimated $2.46M.
  • Jade Biosciences made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3227 holding.
  • Invesco first reported a position in Jade Biosciences in Q4 2022 and has held it in 5 quarters since.
  • Invesco's Jade Biosciences position peaked at $3.08M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.